Current partner codePEPTIDESDE
Evidence dashboardStudies since 2015Updated Jul 31, 2026

BPC-157Clinical Trials.

A source-linked view of every BPC-157 study in the current snapshot—status, phase, enrollment, results, publications, locations and changes over time.

Total trials
2
Recruiting
1
Completed
0
Terminated
0
Results posted
0
Average enrollment
81
Countries
2
Highest phase
Phase 2

Developer / research origin

Academic / multiple

Evidence summary

Activity is not efficacy.

BPC-157 appears in 2 indexed studies: 1 recruiting, 0 completed and 0 with registry results posted. The highest registered development stage in this snapshot is Phase 2. These counts measure registry activity; they do not establish that BPC-157 is safe or effective.

Review the design, endpoints, population, protocol changes, statistical analysis and publications before drawing conclusions.

Development history

Trial timeline.

Evidence timeline

20152026

Velocity

BPC-157 studies by start year

Study start year · indexed snapshot

1110020152015: 1 trials2016: 0 trials20172017: 0 trials2018: 0 trials20192019: 0 trials2020: 0 trials20212021: 0 trials2022: 0 trials20232023: 0 trials2024: 0 trials20252025: 0 trials20262026: 1 trials

Development

Trials by phase

Early Phase 10
Phase 11
Phase 21
Phase 30
Phase 40

Current studies

Recruiting or active

Completed studies

Finished records

Stopped studies

Withdrawn or terminated

No studies in this snapshot.
No studies in this snapshot.

Full study index

Search BPC-157 trials.

Add status, phase, condition, country, result and publication filters inside this molecule’s indexed study set.

2 matching studies

End of 2 results

Latest publications

Follow the paper trail.

No PMID-linked publications are present in the indexed registry records for this molecule.